m.vukovic
TL2 · Ibadan
Contributes reviews on supplier material. Based in Ibadan.
Joined 24 July 2025 · last posted 4d
77 posts, newest first. Showing up to 150.
-
Reused chromatograms across lots: how to spot it Replied, post #60 · Analytics › COA interpretation · 24 Jul 2026 · 23 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #7 · Clinical › Prescriber conversations · 17 Jul 2026 · 25 likes On post #3 — agreed on the reasoning, with one qualification. A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #72 · Analytics › Home & field testing · 14 Jul 2026 · 15 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #19 · Practice › Interactions · 12 Jul 2026 · 0 likes Post #18 answers the question as asked. The question underneath it is different. Where the Delayed gastric emptying and oral discussion usually stalls is that nobody…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #41 · Clinical › Comorbidities · 12 Jul 2026 · 25 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #17 · Sourcing › Payments · 9 Jul 2026 · 0 likes Post #16 answers the question as asked. The question underneath it is different. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery…
-
Reading a home test result without over-claiming Replied, post #110 · Analytics › Home & field testing · 8 Jul 2026 · 12 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #64 · Analytics › Impurities & related substances · 2 Jul 2026 · 11 likes On post #62 — agreed on the reasoning, with one qualification. Endotoxin: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #25 · Practice › Side effects · 2 Jul 2026 · 18 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Asking a follow-up: new topic or new reply? Replied, post #25 · Start Here › How to Ask · 26 Jun 2026 · 15 likes This follows post #22 rather than contradicting it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #6 · Research Methods › N-of-1 designs · 21 Jun 2026 · 25 likes Building on post #5 rather than restating it. Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress).…
-
Revisiting: The best-written scientific paper you have read Replied, post #43 · Lounge › Off topic · 21 Jun 2026 · 3 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic. If…
-
An 18-month record including the parts that went badly Replied, post #45 · Outcomes › Progress reports · 19 Jun 2026 · 15 likes What would change my mind on 18-month record is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #28 · Pharmacology › Pharmacokinetics · 18 Jun 2026 · 2 likes A definition problem is doing most of the work in this Peak-to-trough ratio discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #20 · Sourcing › Independent verification · 15 Jun 2026 · 32 likes Picking up post #19: that is the part I would want checked first. The record shows what was measured. Everything beyond that is inference and this site tries to keep…
-
Forced degradation studies: designing one that is informative Replied, post #74 · Analytics › Method validation · 11 Jun 2026 · 26 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #64 · Sourcing › Red flags · 5 Jun 2026 · 9 likes Second-hand on certificate whose chromatogram axes, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #65 · Start Here › Welcome · 29 May 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #42 · Devices › Syringes & needles · 16 May 2026 · 1 like Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Coming back to: Time to steady state after a dose increase Replied, post #51 · Pharmacology › Pharmacokinetics · 11 May 2026 · 0 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #44 · Clinical › Comorbidities · 11 May 2026 · 19 likes Post #41 is the version of this I will quote in future. One addition. Where I would push back on the gastro-oesophageal reflux consensus is the confidence, not the…
-
A promotion I argued against, and why I lost — a second dataset Replied, post #4 · Documentation › Doc review · 3 May 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. Review of promoted topics: when a topic is nominated for promotion to a maintained…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #116 · Practice › Reconstitution · 25 Apr 2026 · 21 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #48 · Practice › Administration · 22 Apr 2026 · 0 likes What I can speak to on Pinch is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #3 · Analytics › Impurities & related substances · 21 Apr 2026 · 4 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
-
Spike-and-recover accuracy for a peptide assay Replied, post #10 · Analytics › Method validation · 7 Apr 2026 · 19 likes Where I have landed on spike-and-recover accuracy, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #11 · Data & Tools › Calculators · 2 Apr 2026 · 0 likes Post #8 is right about the mechanism and I think understates the practical bit. Unit-conversion tools are only as good as the assumption they make about the syringe.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #24 · Evidence › Journal club · 26 Mar 2026 · 1 like People arriving without having read it should be welcome and should say so, because a question from someone who has not read it frequently exposes an assumption…
-
When a network meta-analysis is defensible and when it is not Started this topic · Evidence › Meta-analyses · 22 Mar 2026 · 18 likes When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Network…
-
Grapefruit: why this class is not the class that cares Replied, post #49 · Practice › Interactions · 17 Mar 2026 · 3 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #2 · Start Here › Welcome · 1 Mar 2026 · 26 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Measurement error in a self-reported exposure Replied, post #39 · Evidence › Study critique · 23 Feb 2026 · 13 likes Everything in post #35 holds. The case it does not cover is the one I have. I would keep measurement error and the decision it usually gets used for separate in this…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #62 · Practice › Storage & stability · 12 Feb 2026 · 1 like Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #89 · Wellbeing › Mental health · 10 Feb 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed Anxiety, as opposed to read about it? The thread is long and I cannot tell.
-
Revisiting: Sample handling between despatch and injection Replied, post #6 · Analytics › Method validation · 14 Jan 2026 · 0 likes Post #2 put the caveat in the right place and I want to underline it. Linearity across the working range is a routine demonstration and it constrains how far a result…
-
The headache that turns out to be dehydration Replied, post #115 · Nutrition & Training › Hydration & electrolytes · 29 Dec 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
What "verified" means on our vendor pages, stated narrowly Started this topic · Sourcing › Vendor reports · 21 Dec 2025 · 0 likes What "verified" means on our vendor pages, stated narrowly — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how…
-
DXA precision and the least significant change for lean mass Replied, post #66 · Outcomes › Body composition · 13 Dec 2025 · 30 likes Coming back to post #64, because the follow-up matters more than the original answer. Preserving lean tissue during a substantial deficit depends on protein intake and…
-
Reading SURMOUNT-1 without the press release Replied, post #97 · Compounds › Tirzepatide · 11 Dec 2025 · 0 likes The reason reading SURMOUNT-1 without the press keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the…
-
Request: export my own posts — one year on Replied, post #19 · Meta › Feature requests · 5 Dec 2025 · 2 likes Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline, and site search is optimised for finding other people's…
-
Documentation that materially improves an appeal's chances Replied, post #79 · Access › Insurance & coverage · 26 Nov 2025 · 0 likes Picking up post #78: that is the part I would want checked first. Where a criterion requires documented prior attempts, the documentation has to exist in the record…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #78 · Compounds › Other compounds · 25 Nov 2025 · 5 likes Sequence verification is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Pen dose counters: what a click does and does not guarantee Replied, post #28 · Devices › Pens & autoinjectors · 14 Nov 2025 · 19 likes Where I part company with post #26, and it is a narrow parting. Storage after first use: most pens can be stored at room temperature after first use, even if…
-
Persistent vomiting and the threshold for seeking help Replied, post #66 · Safety › Adverse events · 10 Nov 2025 · 0 likes Distinguishing three things in the persistent vomiting discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Availability by country, dated, with primary sources Replied, post #51 · Access › International · 8 Nov 2025 · 17 likes Worth separating two things that post #47 runs together. Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the…
-
Sleep tracking data and its considerable limitations Replied, post #120 · Wellbeing › Sleep · 29 Oct 2025 · 19 likes Taking post #119 at face value and following it one step further. The honest answer on sleep is that it depends, and the useful part is the list of what it depends on.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #65 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 13 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #34 · Pharmacology › Receptor biology · 1 Sep 2025 · 0 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Receptor desensitisation and internalisation are real phenomena in vitro and their…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Started this topic · Compounds › Retatrutide · 27 Aug 2025 · 3 likes On the subject in the title: Retatrutide's phase 2 heart-rate signal and how to think about it Working notes rather than a conclusion. Putting the numbers in the first…
-
Are there stupid questions here? A staff answer, at length Replied, post #114 · Start Here › Welcome · 26 Aug 2025 · 4 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #72 · Compounds › Secretagogues & GH axis · 17 Aug 2025 · 0 likes Post #68 put the caveat in the right place and I want to underline it. On analysis: these are short peptides and generally straightforward chromatographically, which…
-
Comparing my trajectory with the trial curves, carefully Replied, post #34 · Outcomes › Progress reports · 10 Aug 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
A ten-fold dose error caught before injection — one year on Replied, post #22 · Devices › Syringes & needles · 1 Aug 2025 · 5 likes Answering the question post #18 raises rather than the one it answers. Check what the graduations actually say rather than what you expect. A syringe marked in units…
-
When a preprint is the best available evidence and we say so Replied, post #7 · Evidence › Preprints · 29 Jul 2025 · 22 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #51 · Devices › Cold chain · 16 Jul 2025 · 21 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Triple agonism: additive, synergistic, or neither? Replied, post #61 · Compounds › Retatrutide · 26 Jun 2025 · 0 likes Worth separating two things that post #59 runs together. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #117 · Compounds › Tirzepatide · 22 Jun 2025 · 3 likes That reframing is the whole thing. The facts I already had.
-
Coming back to: Official shortage notices and what they authorise Replied, post #20 · Access › Shortages · 3 Jun 2025 · 31 likes I read the earlier replies on Official shortage notices twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #14 · Devices › Syringes & needles · 21 Apr 2025 · 0 likes Distinguishing three things in the Filter needles discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #18 · Clinical › Comorbidities · 15 Apr 2025 · 20 likes This is the sort of exchange that makes the archive worth searching.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #34 · Wellbeing › Mental health · 15 Apr 2025 · 2 likes Reporting rather than recommending, on history of disordered eating. What happened is above. Whether it should have is a different question and not one I am qualified…
-
Charge states for a 4 kDa peptide, worked through Replied, post #100 · Analytics › Mass spectrometry · 14 Mar 2025 · 7 likes This follows post #99 rather than contradicting it. Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Started this topic · Compounds › Oral incretins · 22 Feb 2025 · 14 likes Asking directly, because I could not find a straight answer: Why fasting instructions for oral semaglutide are not optional advice — does this still hold? A methods…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #9 · Practice › Dosing & titration · 15 Feb 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
What a seizure notice actually says Replied, post #26 · Sourcing › Logistics · 21 Jan 2025 · 4 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #91 · Compounds › Tirzepatide · 29 Dec 2024 · 16 likes The arithmetic in post #88 is right; the assumption feeding it is the part to check. Injection-site reactions were reported at a low but non-zero rate across the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #89 · Compounds › Oral incretins · 27 Dec 2024 · 6 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #3 · Meta › Wiki maintenance · 26 Dec 2024 · 10 likes The opening post describes the usual case. This is about the unusual one. That matches how I use it. The general statement is what you check afterwards, not what you…
-
Body image changing more slowly than the body Replied, post #16 · Wellbeing › Mental health · 12 Dec 2024 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #21 · Evidence › Journal club · 30 Nov 2024 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I have said this before in a thread nobody could…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #4 · Compounds › Repair & healing peptides · 16 Nov 2024 · 9 likes Adding a small correction to the TB-500 and thymosin beta-4 summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor…
-
Time to steady state after a dose increase Replied, post #164 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 6 likes Post #161 is right about the mechanism and I think understates the practical bit. Steady state is approached in roughly four to five half-lives. For a compound with a…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #35 · Clinical › Comorbidities · 14 Oct 2024 · 2 likes A request rather than an answer: could whoever has the primary source for Hypertension improvement post it? I have seen the claim three times this month and each…
-
Correlation in a self-tracked dataset: what it can support Replied, post #37 · Research Methods › Statistics · 21 Aug 2024 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #8 · Compounds › Semaglutide · 15 Aug 2024 · 0 likes C-cell question: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Blind submission and why it changes minds Replied, post #2 · Sourcing › Independent verification · 19 Jun 2024 · 1 like Thank you for taking the time. That was more work than a reply usually is.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #5 · Practice › Dosing & titration · 25 May 2024 · 27 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…